Tech Company Financing Transactions

Xytis Funding Round

Sanderling Ventures and Atlas Venture participated in a $24.5 million Series B funding round for Xytis. The round was announced on 1/9/2006.

Transaction Overview

Company Information

Company Status

Out of Business

Industry

Biopharmaceutical

Mailing Address

101 Theory 100
Irvine, CA 92617
USA

Phone

(949) 725-3700

Website

www.xytis.com

Email Address

[email protected]

Overview

Xytis Inc. is a biopharmaceutical company focusing on the discovery and development of innovative CNS drug candidates.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Vincent Simmon

        

Browse more venture capital transactions:

Prev: 1/9/2006: Tioga Pharmaceuticals venture capital transaction
Next: 1/9/2006: ZONARE Medical Systems venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary